Bisphenol a induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist

Nutrition and Diabetes

Volumn 4, Issue JANUARY, 2014, Pages

  Boucher, J G ^a   Boudreau, A ^a   Atlas, E ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Adipocyte; Bisphenol A; Endocrine disruptor; Estrogen receptor; Glucocorticoid receptor; Obesity

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AP2 PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENT FACTOR D; ESTRADIOL; INSULIN; ISOBUTYLMETHYLXANTHINE; MIFEPRISTONE; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION;

EID: 84898741909     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2013.43     Document Type: Article

References (54)

1. Allender S, Rayner M. The burden of overweight and obesity-related ill health in the UK. Obes Rev 2007; 8: 467-473.
2. Decherf S, Demeneix BA. The obesogen hypothesis: a shift of focus from the periphery to the hypothalamus. J Toxicol Environ Health B Crit Rev 2011; 14: 423-448.
3. Vom Saal FS, Nagel SC, Coe BL, Angle BM, Taylor JA. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 2012; 354: 74-84.
4. Fleisch AF, Sheffield PE, Chinn C, Edelstein BL, Landrigan PJ. Bisphenol A and related compounds in dental materials. Pediatrics 2010; 126: 760-768.
5. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127: 27-34.
6. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24: 139-177.
7. Dekant W, Volkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008; 228: 114-134.
8. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118: 1055-1070.
9. Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in US children. Am J Epidemiol 2013; 177: 1263-1270.
10. Harley KG, Schall RA, Chevrier J, Tyler K, Aguirre H, Bradman A et al. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect 2013; 121: 514-520.
11. Gong H, Zhang X, Cheng B, Sun Y, Li C, Li T et al. Bisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetes. PLoS One 2013; 8: e54198.
12. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84: 319-327.
13. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 2009; 117: 1549-1555.
14. Wang J, Sun B, Hou M, Pan X, Li X. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11beta-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children. Int J Obes 2012; 37: 999-1005.
15. Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 2012; 81: 715-736.
16. Tomlinson JJ, Boudreau A, Wu D, Atlas E, Hache RJ. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology 2006; 147: 5284-5293.
17. Lechner S, Mitterberger MC, Mattesich M, Zwerschke W. Role of C/EBPbeta-LAP and C/EBPbeta-LIP in early adipogenic differentiation of human white adipose-derived progenitors and at later stages in immature adipocytes. Differ Res Biol Divers 2013; 85: 20-31.
18. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007; 24: 178-198.
19. Ben-Jonathan N, Steinmetz R. Xenoestrogens: the emerging story of bisphenol A. Trends Endocrinol Metab 1998; 9: 124-128.
20. Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-alpha and GPER signalling. Mol Cell Endocrinol 2012; 351: 269-278.
21. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity 2010; 18: 1283-1288.
22. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res 2002; 17: 394-405.
23. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K et al. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem 2000; 275: 11404-11411.
24. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 2002; 143: 2349-2356.
25. Couse JF, Korach KS. Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol 1999; 60: 143-148.
26. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, Gauthier BR et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 2008; 3: e2069.
27. Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H et al. Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J Biochem 2007; 142: 517-524.
28. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect 2008; 116: 32-38.
29. Sheng ZG, Huang W, Liu YX, Zhu BZ. Bisphenol A at a low concentration boosts mouse spermatogonial cell proliferation by inducing the G protein-coupled receptor 30 expression. Toxicol Appl Pharmacol 2013; 267: 88-94.
30. Teng C, Goodwin B, Shockley K, Xia M, Huang R, Norris J et al. Bisphenol A affects androgen receptor function via multiple mechanisms. Chem Biol Interact 2013; 203: 556-564.
31. Abdou HS, Atlas E, Hache RJ. A positive regulatory domain in CCAAT/enhancer binding protein beta (C/EBPBeta) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpalpha promoter and maximum adipogenesis. Endocrinology 2013; 154: 1454-1464.
32. Hamm JK, Park BH, Farmer SR. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem 2001; 276: 18464-18471.
33. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008; 116: 1642-1647.
34. Lee MJ, Gong DW, Burkey BF, Fried SK. Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study. Am J Physiol Endocrinol Metab 2011; 300: E571-E580.
35. Kuri-Harcuch W, Wise LS, Green H. Interruption of the adipose conversion of 3T3 cells by biotin deficiency: differentiation without triglyceride accumulation. Cell 1978; 14: 53-59.
36. Li Y, Burns KA, Arao Y, Luh CJ, Korach KS. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor alpha and beta in vitro. Environ Health Perspect 2012; 120: 1029-1035.
37. Zhang P, O'Loughlin L, Brindley DN, Reue K. Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis. J Lipid Res 2008; 49: 1519-1528.
38. Havel PJ, Busch BL, Curry DL, Johnson PR, Dallman MF, Stern JS. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats. Am J Physiol 1996; 271(3 Pt 2): R710-R717.
39. Pereira-Fernandes A, Demaegdt H, Vandermeiren K, Hectors TL, Jorens PG, Blust R et al. Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PLoS One 2013; 8: e77481.
40. Soriano S, Alonso-Magdalena P, Garcia-Arevalo M, Novials A, Muhammed SJ, Salehi A et al. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta. PLoS One 2012; 7: e31109.
41. Chamorro-Garcia R, Kirchner S, Li X, Janesick A, Casey SC, Chow C et al. Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Environ Health Perspect 2012; 120: 984-989.
42. Hsieh TJ, Lin T, Hsieh PC, Liao MC, Shin SJ. Suppression of glutamine:fructose-6- phosphate amidotransferase-1 inhibits adipogenesis in 3T3-L1 adipocytes. J Cell Physiol 2012; 227: 108-115.
43. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A et al. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ Health Perspect 2011; 119: 1227-1232.
44. Linehan C, Gupta S, Samali A, O'Connor L. Bisphenol A-mediated suppression of LPL gene expression inhibits triglyceride accumulation during adipogenic differentiation of human adult stem cells. PLoS One 2012; 7: e36109.
45. Hao CJ, Cheng XJ, Xia HF, Ma X. The endocrine disruptor diethylstilbestrol induces adipocyte differentiation and promotes obesity in mice. Toxicol Appl Pharmacol 2012; 263: 102-110.
46. Joyner JM, Hutley LJ, Cameron DP. Estrogen receptors in human preadipocytes. Endocrine 2001; 15: 225-230.
47. Hwang KA, Kang NH, Yi BR, Lee HR, Park MA, Choi KC. Genistein a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17betaestradiol or bisphenol A via the inhibition of cell cycle progression. Int J Oncol 2013; 42: 733-740.
48. Abad MC, Askari H, O'Neill J, Klinger AL, Milligan C, Lewandowski F et al. Structural determination of estrogen-related receptor gamma in the presence of phenol derivative compounds. J Steroid Biochem Mol Biol 2008; 108: 44-54.
49. Park K, Kwak IS. Molecular effects of endocrine-disrupting chemicals on the Chironomus riparius estrogen-related receptor gene. Chemosphere 2010; 79: 934-941.
50. Ijichi N, Ikeda K, Horie-Inoue K, Yagi K, Okazaki Y, Inoue S. Estrogen-related receptor alpha modulates the expression of adipogenesis-related genes during adipocyte differentiation. Biochem Biophys Res Commun 2007; 358: 813-818.
51. Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol 2003; 23: 7947-7956.
52. Ju D, He J, Zhao L, Zheng X, Yang G. Estrogen related receptor alpha-induced adipogenesis is PGC-1beta-dependent. Mol Biol Rep 2012; 39: 3343-3354.
53. Sheng ZG, Zhu BZ. Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-alpha. Environ Health Perspect 2011; 119: 1775-1780.
54. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 2009; 304: 49-54.